Evaluation of PET Scan Timing Relative to AV-45 Injection Time
NCT01565356
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
florbetapir F 18
Sponsor
Avid Radiopharmaceuticals